PaTLA: fostering public awareness and understanding of the role of the trial lawyer in the administration of justice.

Shopping Cart

Home News & Case Notes Inquirer: Drug ads pour in for review The FDA said it had seen "a huge increase" in advertising submitted for scrutiny under a voluntary industry program. (2/23/2006) - The Philadelphia Inquirer reports today on the U.S. Food and Drug Administration announcement that drugmakers had flooded it with commercials for review under their new advertising-ethics code. According to the Inquirer, Thomas W. Abrams, director of the FDA division that scrutinizes drug advertising for accuracy, reported receiving "a huge increase" in print ads, TV and radio spots, and scripts in the months since the industry trade group called on companies voluntarily to submit them for advance scrutiny, in response to concerns about misleading, false or inappropriate advertising. Link to article on Philly.com